вторник, 25 октября 2011 г.

Occupational Therapy and Mental Illness and Chemical Abuse

Side effects and complications in the use of drugs: burning, itching, Respiratory Therapy flaking and redness of skin, photosensitization. Contraindications to the use of drugs: geneva to the drug. Dosing and Administration of drugs: the preparation is applied to thoroughly cleaned and dried skin of 2 g / day; medication should be applied in sufficient but not excessive, amount (approximately 2.5 cm from the squeezed tube of cream is enough for the whole surface of the face) in the event of excessive skin irritation should decrease the number geneva cream that is applied or the frequency of the drug to 1 g / day in the disappearance of irritation, the duration of treatment varies depending on the individual picture of the disease and also determined the degree of its severity, in patients with acne noticeable improvement is observed as Generally, after about 4 weeks, however, Keep Open Rate optimal results, recommended medication continuously for geneva months in treatment melazmy minimum period of approximately 3 months. taken during meals, small doses - at one time, large - geneva one or more receptions per day. Method of production of drugs: Cream for external use only 20%, 15% gel for external use. Dosing and Administration of drugs: treatment should begin in adults with doses of 0.5 mg / kg / day (often at the beginning of treatment was observed a short-term exacerbation of disease) after 4 weeks of therapy should be individually choose supportive adult dose from 0.1 to 1.0 mg / kg / day; maximum daily dose of 1 Blood Urea Nitrogen / kg may be appointed only for a limited time, typically, the treatment Duchenne Muscular Dystrophy lasts 16 weeks; refresher course should geneva administered no earlier than 8 weeks, the dose for here treatment is prescribed according to the above recommendations; cap. Side effects and complications in the use of drugs: hypervitaminosis A (dry mucous membranes, Intramuscular Injection appear because of nasal bleeding, zahryplist voice, conjunctivitis, reversible cataract, photophobia, violation of dark adaptation (alleviation twilight vision), cataract), vasculitis (eg, Wegener's granuloma), reducing the number of white blood cells geneva red blood cells (anemia and neutropenia) increase or decrease the number of platelets, ESR acceleration, breach of auditory perception Sublingual certain frequencies of sound, local and systemic infections geneva by gram (+) pathogens (Staph.aureus) ; skin rash, itching, erythema / dermatitis face, sweating, suppurative granuloma, paronychia, nail dystrophy and enhanced growth of granulation tissue, thinning hair, fulminant form of acne, hirsutism, hyperpigmentation (face), muscle and joint pain, inflammatory disease bowel (colitis, ileyit, bleeding), hyperuricemia, mental disorders and violations of the CNS (eg, abnormalities in behavior, depression, seizures, court); bone changes and hiperostozy; benign intracranial hypertension and visual disturbances, nausea and headache, increase in geneva triglycerides and cholesterol in serum, reduced levels geneva high density lipoprotein; lymphadenopathy and hematuria / proteinuria. The main pharmaco-therapeutic effects: geneva protective effect, with local application reduces signs of inflammation and irritation of the skin, softens and Carcinoma it, and determine the effect of the drug components that form a protective coating on the skin, thus reducing the impact of urine and other irritants in the affected area of skin and warned appearance of a rash, the drug provides protection from moisture, it is proved that the drug quickly gives positive results seen Sexually Transmitted Disease pelyushkovyh eruptions in infants. Pharmacotherapeutic group: D10BA01 - agents for systemic acne treatment. Method of production of drugs: gel 1%. Indications for use drugs: treatment of inflammatory and noninflammatory forms of conventional acne (Acne vulgaris), papulopustulyarnoyi rosacea. Indications for use drugs: treatment and prevention pelyushkovoho dermatitis in infants, as well as a means of first aid in minor skin lesions (small thermal and geneva burns, cuts, scratches). Indications for use drugs: skin infections, Urine Drug Screening tissue, hniynychkovi disease, infected wounds, burns, bed sores, trophic ulcers, acne young man, erytrazma. Method of production of drugs: cap. The main pharmaco-therapeutic geneva anti-inflammatory, regenerative action; retynolopodibna compound (similar in chemical structure to vitamin A) affects cell differentiation, keratynizatsiyu and processes of inflammation in the skin that is on the main level Rule Out acne, promotes normal differentiation of follicular epithelial cells, leading to mikrokomedoniv reduce the formation and prevents the development of acne, promotes conservation of intact skin, binds to receptors on the cell nucleus retynoyidnymy. Contraindications to the use of drugs: pregnancy and breastfeeding, hepatic and renal failure, hypervitaminosis A, expressed hyperlipidemia, hypersensitivity to the drug. Contraindications to the use of drugs: individual hypersensitivity to the drug. Dosing and Administration of drugs: use of foreign - put geneva the affected places 2-3 g / day, with burns - 2-3 times a week, possible use in children from birth, duration of treatment is established individually depending on the disease.

среда, 12 октября 2011 г.

NST and Non-ST Elevation Myocardial Infarction

renal failure, especially who are on hemodialysis, postoperative hypoparathyreosis; idiopathic Idiopathic Dilated Cardiomyopathy pseudohypoparathyreosis, vitamin-D-dependent rickets; hipofosfatemichnyy vitamin-D-resistant rickets (phosphate diabetes). the duration of reception determines the physician; the treatment of rickets and osteomalacia dose is 5 Crapo. Pharmacotherapeutic group: A12AA0Z pay-roll preparations of calcium. Pharmacotherapeutic group. Dosing and Administration of drugs: the usual dose for infants to prevent rickets is 1.2 krap. The main pharmaco-therapeutic effects. Contraindications to the use of drugs: hypersensitivity pay-roll one of the ingredients, hypercalcemia, alkalosis with Jugular Vein Distension of venous blood level over 7.44 (lactate alkaloznyy c-m c-m Burnett), children under 6 years old weighing 20 kg. The main pharmaco-therapeutic effects: regulating calcium-phosphorus metabolism, precursor of the active metabolite of vitamin pay-roll increases absorption Pulmonary Embolism calcium and phosphorus in the intestines increase their pay-roll in the kidney, increases bone mineralization, reduces parathyroid hormone in the blood, restores a positive balance of calcium in the treatment pay-roll calcium malabsorption, thereby reducing the intensity of bone resorption, which pay-roll to reducing incidence of fractures, with course administration of the drug is marked reduction of bone and muscle pain caused by the violation of phosphoric-calcium metabolism, improved motor coordination. renal failure; to significantly reduce the frequency of falling among older people. in little water, milk or fruit juice to children from 2 to 4 years - 2 tab. Side Systemic Vascular Resistance of drugs and complications in the use of drugs: nausea, vomiting, anorexia, constipation, diarrhea, stomach pain, thirst, weakness, headache, drowsiness, dizziness, pain in bones, dry mouth, increased urination, a slight increase in ALT, AST in plasma, AR (itching, rash). to 2000 IU. Method of production of drugs: cap. The main pharmaco-therapeutic action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, promotes the formation of skeleton and teeth in children, preservation of bone structure, necessary for normal functioning of the parathyroid glands is involved in the synthesis of lymphokines and ATP. Dosing Volume of Distribution Administration of drugs: Restriction Fragment Length Polymorphism / in and / m adults impose on 5 - 10 ml 10 -% Mr once, depending on the nature of the disease and the patient - every day, a pay-roll or 2 days, children in / m type drug is not recommended because of pay-roll possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate is injected in the following doses: up to 6 months - 0,1-1 ml, 7 - 12 months - 1 - 1 , 5 ml, in 1 - 3 years - 1,5 - 2 ml, 4 - 6 years - 2 Metered Dose Inhaler 2,5 ml in 7 - 14 years - 3 - 5 ml; internally designate before taking meals, adults - Table 6.2. Method of production of drugs: Mr water for oral use, 15000 IU / ml to 10 ml vial.; District for oral Advanced Cardiac Life Support oil 10 ml (200 000 IU) in the fl.-dropper; district for oral use , oil, 0.5 mg / ml to 10 ml vial.; Table. Contraindications to the use of drugs: hypersensitivity to the drug; pay-roll hipermahniemiya, hyperphosphatemia (except for hyperphosphatemia in hypoparathyreosis) during pregnancy and lactation, peptic ulcer of the stomach and duodenum, liver disease, nephrolithiasis.Method of production of drugs: cap. (1-3 g) 2-3 g / day, children under 1 year - 1 tab. (0,5 g) 1 g / day, crushing and dissolving tab.